[ Price : $8.95]
An unusually strident Wall Street Journal editorial apologizes to its readers for supporting FDA commissioner Robert Califfs appoi...[ Price : $8.95]
Regeneron faces a potential approval delay on its supplemental BLA for Dupixent (dupilumab) as an add-on maintenance treatment in ...[ Price : $8.95]
A just-introduced bill, Fixing Administrations Unethical Corrupt Influence Act, restricts top federal health officials at FDA, CDC...[ Price : $8.95]
FDA increases its surveillance of promotional materials during inspections, according to a client bulletin by Arnall Golden Gregor...[ Price : $8.95]
FDA announces an 8/16 public meeting on Evaluating the Negative Symptoms of Schizophrenia in Clinical Trials to discuss approaches...[ Price : $8.95]
FDA issues Eugia Pharma Specialities its fourth Form FDA-483 of the year after concluding an inspection of the firms formulation m...[ Price : $8.95]
Federal Register notice: FDA issues an order permanently debarring Angela Maria Giron from providing services in any capacity to a...[ Price : $8.95]
Hyman, Phelps & McNamara senior medical device regulation expert Lisa Baumhardt critiques a recent FDA draft guidance on the Q-Sub...